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ABSTRACT 
 Pharmaceutical companies are increasingly infusing the concept of agility 
to strive for continuous improvement. Significant exploration and research have 
focused on more technical-driven departments, like Information Technology and 
Research and Development. However, there has been little research with the 
focus on more process-driven functions, like Learning and Organizational 
Development. This action research study presents a case study of the 
implementation of a new training solution within a consumer healthcare 
organization from the lens of the project leader. Building upon the case study, 
this capstone includes a review of existing research and literature of agility with 
a focus on the healthcare sector, change management, adult learning, and 
organizational learning. The overall goal of this study is to explore the value of 
agility in building learning capacities within the pharmaceutical industry. Looking 
forward, the aim is to provide insights on how agility can be developed to 
facilitate an organization’s transformation to become a learning organization. 
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CHAPTER 1 
INTRODUCTION 
 
 The first known use of “agile” was in the 14th century. The word was 
borrowed from Middle French and is defined as “having quickness of motion, 
nimble, active” (Etymology Dictionary, n.d.). 
 Now, agile related topics have widely attracted attention in industry 
research and academia. Pharmaceutical companies are increasingly infusing 
the concept of agility (referring to a set of mindsets, behaviors, and skills) into 
their operation models and to further re-engineer the organization. Significant 
exploration and research have focused on more technical-driven departments, 
like Information Technology (IT) and Research and Development (R&D) 
(Mahadevan, Paquette, Rashid, & Ustinov, 2019). However, there has been little 
research written with the focus on more process-driven functions, such as 
Learning and Organizational Development. This capstone presents a case 
study of the use of agility as guidance to implement a new training solution 
within the Consumer Healthcare R&D of a multinational pharmaceutical 
company. 
 The case recounts my independent study advised by Dr. Charline Russo 
through the lens of my role as the project leader of the implementation of a new 
training solution. Building upon the case study, the capstone paper includes, but 
is not limited to, a review of existing research and literature of agility with a focus 
on the healthcare sector, change management, adult learning, and 
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organizational learning.  
 The overall goal of this capstone paper is to explore the principles of 
agility in building an organization’s learning capability, specifically within the 
pharmaceutical industry (herein pharma). It also hopes to provide insights on 
how agility can be developed to facilitate an organization’s transition to a 
learning organization (Garvin, Edmondson, & Gino, 2008). It is assumed that 
learning organizations can better adapt to the unpredictable, especially in the 
era of economic globalization and in the knowledge economy.  
 
Background and Context  
 In an organization, continuous improvement and innovation are important 
to ensure long-term success in a dynamic environment. However, in a highly 
regulated industry like pharma, it seems there is a paradox between stability 
and dynamics and a primary tension between purpose and safety (Fried, 2017). 
Constant change seems to be the only thing that does not change in this 
industry. Like a living organism, pharma needs both backbone elements and 
fresh blood. The former strives for sustainable excellence to provide safe and 
high-quality solutions. The latter injects dynamic capabilities (Teece, Peteraf, & 
Leih, 2016) to adapt to constant changes. However, injecting the dynamic 
capacities into pharma is sometimes like renovating a big house by doing 
everything many times. It is a process that proceeds with small-fit-for purpose 
performance steps, or say, in an agile way.  
 The dynamics capabilities have been traditionally related to more 
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technical-driven areas, like IT and R&D (Mahadevan et al., 2019). To a great 
degree, this also explains why major attention and resources to agility have 
been predominantly allocated to these areas in pharma and research study. As 
the culture of continuous improvement has increasingly permeated in various 
functions in healthcare organizations (Chandrasekaran & Toussaint, 2019), it is 
worth studying the value of building agility in other process-driven functions, 
such as Learning and Organizational Development. This capstone hopes to 
potentially minimize the current research gap.  
 In addition, it also expects to provide perspectives and guidance to 
practitioners like me in the learning and organizational development field. In the 
last five years, my professional work primarily focused on project management, 
particularly in the areas of medical-related continuing education and executive 
leadership development. My experiences and observations lead me to believe 
that learning plays a crucial role in both professional advancement and 
organizational development. Now as a full-time graduate student with a major in 
Organizational Dynamics and a great interest in the healthcare industry, I hope 
that this capstone will also contribute to my future roles as an organizational 
development consultant and a professional in the healthcare industry.  
 
Case Overview 
 The case is developed solely for the learning objectives of this capstone 
study. Actual names of people, the company, and any other identifiable 
information have been altered to preserve confidentiality and privacy.   
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 In the summer of 2019, I was employed by BrownNeilsonCarr (herein 
BNC), one of the world’s largest pharmaceutical companies, as the project 
leader to implement a new training solution to its Consumer Healthcare R&D 
(herein CHRD). The overarching goal of this solution was to ensure that the 
Technical Excellence and Operations (herein TEX) scientists verify the 
compliance status of their equipment and process training and bridge the 
required knowledge gap before performing the related activity. It was designed 
to replace the existing solution. 
 As a multinational company, BNC has offices in over 120 countries. It has 
three global businesses that research, develop and manufacture 
pharmaceutical medicines, vaccines, and consumer healthcare products. Each 
business has a broad portfolio of innovative and established products that effect 
people living in nearly all countries in the world. To further strengthen its 
pharmaceutical and vaccine R&D pipelines and businesses, the company 
announced in 2018 that it would separate its consumer healthcare business 
through a joint venture with its major rival. This global integration transaction 
was expected to be completed within three years and has influenced every unit 
and its daily operations. The senior leadership team and the integration office 
communicated with the following message:  
  “BNC Consumer Healthcare (herein BNC CH) is a big muscle to move 
with around 30,000 employees, brands that are sold in over 100 markets, and 
36 manufactures sites. So how do we fight the complexity and start moving our 
muscles to make things happen? We need to deliver the integration plans to 
minimize uncertainty, maximize opportunities and deliver synergy commitment.” 
(BNC Internal Communication, 2018) 
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 Agility was considered as one of the most important attributes to lead this 
integration. Employees were encouraged to be more courageous and 
accountable and involve fewer people in decision-making to facilitate the 
integration happening within the targeted timeline. Using agile approaches to run 
experimental actions first was widely advocated in BNC CH since the integration 
began.   
 The project I led targeted six CHRD major sites across four countries. It 
involved more than 350 TEX scientists who worked on analytics, formulation, 
prototyping and packaging at CHRD laboratories or pilot plants across all product 
categories and brands. An essential part of this project was to introduce a web-
based digital tool called Masterfinder to CHRD. The tool was developed by the 
Vaccine business to fit its business nature and needs. To achieve the project’s 
end goal and ensure a fully successful implementation, a pilot program was 
launched at one of the six sites. The aim was to configure Masterfinder into 
CHRD use at its best and develop a receptive change process for TEX scientists 
to better adapt to the new training solution. Evolving from the pilot program, this 
project was planned to scale up to other sites and achieve the ultimate objective 
to expand the TEX team’s learning and organizational capability.  
 
Literature Review 
 Building on the experiences of the case study, the literature review 
includes, but is not limited to, industry research reports, academic studies, and 
books that explore agility related topics in healthcare and its value in process 
  
6 
management and building learning capability. Considering both my experiences 
and learning objectives, the literature review focuses on the following areas.  
 Agility. Agility has been seen as “the organizational capacity to effectively 
detect, assess and respond to environmental changes in ways that are 
purposeful, decisive and grounded in the will to win.” (Tilman & Jacoby, 2019, p. 
7) According to a recent report published by McKinsey (Mahadevan et al., 2019), 
organizations across sectors from banking to pharma are realizing the immense 
value that agility can bring, especially in building organizational capability and 
continuous improvement. Considered as the hub of innovation, pharma R&D is 
increasingly turning the concept of agility into operations. As the presented case 
takes place at CHRD and agility serves as the implementation’s guiding principle, 
research of agility and its related topics in healthcare grounds the literature 
review.  
 Change. “Change never occurs as some sort of happening; it is part of 
everyday life. All management is change management (Schaffer, 2017, p. 3-4).” 
From setting goals to achieving them, the process is carried out through change, 
no matter whether the change is little or transformative. The “8-Step-Process for 
Leading Change” model (Kotter, 1996), identifies planning and creating short-
term wins as the essential step to renew the process. In the process, employees 
are seen as the most valuable assets for organizations; they are the 
organizations’ secret change agents (Pascale & Sternin, 2005). From the project 
leader’s perspective, the solution implementation presented in the case was a 
process improvement as well as change management. Therefore, it is worth 
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studying related change methodologies and further explore practices to better 
engage employees in the change process.  
 Learning. Learning is commonly recognized as an important attribute to 
inspire organizations to succeed in a dynamic environment. “Teaching people 
how to reason about their behavior in new and more effective ways breaks down 
the defenses that block learning.” (Argyris, 1991, p. 100) Thus, it is necessary to 
review relevant research on adult learning to study how we may facilitate the 
training solution design and implementation within an organization, as well as 
relevant study in the organizational learning field. Three broad factors are 
essential for organizational learning: a supportive learning environment, concrete 
learning processes and practices, and leadership behavior that provides 
reinforcement (Garvin et al., 2008).  
 Building on the research and study, an evaluation of the value that agility 
might unlock in learning capability building follows.  
 
Methodology, Assumptions, and Limitations  
 This capstone study is designed as action research. The detailed case 
serves as the “action” part, and the literature review is the “research” part.  
 The case is presented through the lens of my role as the project leader of 
the solution implementation. Key stages of this implementation process are 
captured in chronological order. As the organization itself was in an integration, 
some relevant organizational background information is also provided to enrich 
the context.  
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 Because the case presents a solution implementation with agility as the 
main guideline in a constant change context, the literature review focuses on 
research and study in the areas related to agility, change management, adult 
learning, and organizational learning. It is a blend of qualitative and quantitative 
perspectives from various industry research reports, academic studies, peer-
reviewed journals, and books. Together with my observations, this case study 
primarily explores the following questions.  
-     Does agility bring value in learning capability building in this case?  
       If so, what is that value?  
-     From expanding individual capability to building a learning     
      organization, how may we, as practitioners, better unlock agility’s     
      value in the process?  
-     What are the challenges and opportunities we need to be aware of    
      when injecting agility in learning capability within an organization?    
 It is assumed that the net benefits (i.e., benefits minus costs) that agility 
brings (Teece et al., 2016) in the presented case are positive. In addition to that, 
learning organizations can better adapt to the unpredictable, especially in the 
era of economic globalization and in the knowledge economy, which serves as 
an important factor to motivate pharma towards continuous improvement and 
innovation.    
 My own assumption is that not all solution implementations always need 
the project leader to have knowledge of organizational dynamics. But for 
situations that have both technical and people components, like the presented 
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case, project leaders with organizational dynamic knowledge can bring 
tremendous value to the implementation process.   
 Although the literature review considers multidimensional perspectives 
from both academia and industry, not all perspectives can be shared in-depth 
within the limited analysis. It by no means serves as an exhaustive review of the 
vast amount of existing resources on each of the above-mentioned areas but 
aims to potentially minimize the current research gap across areas. In addition, 
the case is encapsulated within a defined time period and in the context of an 
organizational integration. To a certain degree, this integration plays a catalyst 
role in the solution implementation process from many aspects. And not all 
observations and events that occurred during the process were incorporated in 
this case. After all, this is a single-case study.  
 
Conclusion  
 The last part of the capstone paper provides a summary of the analysis 
and findings discovered in the case study. It also presents questions and 
research opportunities that were not within the scope of this capstone but might 
be valuable for further exploration. Additionally, it will include my own thoughts 
and reflections in the capstone experience and how this experience has 
influenced me as a committed lifelong learner and a practitioner.   
 The overall goal of this capstone paper is to explore the value of agility in 
building learning capacities within pharma. It also expects to provide insights on 
how agility can be developed to facilitate an organization becoming a learning 
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organization. I believe this paper provides insights for a multitude of 
stakeholders in healthcare, particularly for professionals in learning and 
capability building and leaders in R&D and process improvement. It will be 
relevant to the audiences in other highly regulated industries, such as banking.  
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CHAPTER 2 
THE BNC CASE  
 
  “We are a science-driven global healthcare company with a mission:   to 
help people feel better and live longer.”   
- Company Website 
 
 On a pleasant morning in May 2019, I walked into the BNC Consumer 
Healthcare’s headquarters in New Jersey. Along the lobby, the words “Everyone 
at BNC is focused on three priorities – Innovation, Execution, Care” were 
painted colorfully in a DNA-shaped molecule on canvas.  
 As I arrived at the reception area, Vivian Lauder, Consumer Healthcare 
R&D technical training manager, welcomed me to BNC. She was my line 
manager. After a few minutes of casual conversation, Vivian began my 
company tour. Like many companies, this office site had conference rooms 
named after its flagship products. Many smaller meeting booths were also set 
up for confidential calls and work that required quiet or privacy. Walking around, 
it was surprising to see the unique layout: open floor without any table dividers. 
Vivian explained:  
  “We used to have individual working stations in the office. We moved to 
this location three years ago after an integration. The workplace was changed 
into this flexible seating style in order to increase collaboration and efficiency. 
Technically, you can work at different spots every day. But normally, your team 
would choose to stay around a certain area.”  
 
 Along the corridors, colorful cabinets were placed for employees to store 
their belongings. It brought me back to the vibe of high school. Looking around, 
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people seemed either to be rushing to meetings or deeply involved in their work. 
Slow steps were seen only at the pantries. 
 Getting familiar with the space, I sensed a mixed feeling of excitement 
and nervousness. I wondered what the project would be about; what 
stakeholders, norms, and organizational dynamics I would need to consider in 
managing this project? How could I bring my value to best navigate the 
process? 
 
A History of Striving for Innovation 
  “Since the 1700s in the UK, our story has always focused on innovation. 
Today, we have developed a variety of medicines and healthcare products that 
form the foundations of today’s BNC.”  
- Company Website 
 
 BNC, a science-driven global healthcare company, is headquartered in 
the UK with offices in over 120 countries. It has three global businesses that 
research, develop and manufacture pharmaceutical medicines, vaccines, and 
consumer healthcare products. Each business has a broad portfolio of 
innovative and established products that effect people living in nearly all 
countries in the world. The U.S. is the company’s single largest market and the 
national headquarters is located in Pennsylvania. Across the country, it has 
many offices and manufacturing facilities with a different business focus, 
respectively.  
 The business model of BNC is as straightforward as it is with many major 
pharma. New products are discovered, developed, and launched to markets. It 
then implements continuous improvement and innovation to keep the market 
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share and revenue from shrinking (Garnier, 2008). Some products have turned 
into the powerhouse brands and leaped forward over the competition in their 
areas. Some products may not receive the expected market reaction. Therefore, 
they exit the market or are sold to their rivals.  
 To strive for scientific and technical excellence and to achieve the market 
leader position, R&D drives BNC forward. There are over 16,000 people 
working across the three global businesses in R&D, including highly focused 
centers of excellence and functional units. R&D is seen as a team sport with 
moments of brilliant thinking and hours of painstakingly detailed work (Garnier, 
2008). From 2001 to 2010, BNC R&D was reengineered from an obsolete 
pyramid form of organizational design to a constellation of centers of excellence 
with the purpose to improve transparency and empower scientists with decision-
making autonomy.  
 Fast forward to 2017, the company welcomed its new CEO, Alex Kirby. 
With decades of experience in the fast consumer goods industry, the new CEO 
has injected new perspectives in R&D with an emphasis on developing and 
strengthening external partner relations, particularly with disease-focused 
research institutions and advanced technology companies. The goal was to 
increase the speed of delivering innovative products to the market. In a public 
letter, Kirby wrote:  
  “Since starting in this role it has become an incredible journey for me. 
With more understanding of the challenges and opportunities we confront, I set 
out three long-term priorities on which everyone in the company is now focused: 
Innovation, Execution, and Care. I believe these priorities enable us to focus on 
areas where we can improve and allow us to respond more effectively to our 
operating environment.” (Kirby, 2017) 
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 In keeping with the new vision, digital transformation would begin at 
multiple levels across the pharmaceuticals, vaccine, and consumer healthcare 
businesses.    
 
Integration Leaps Competition Forward  
Continuing Interest in Integration 
 At the end of 2018, BNC announced a separation of its consumer 
healthcare business through a Joint Venture (herein JV) with its major rival, 
Spark, a U.S.-based global healthcare company. According to the press release 
(BNC, Company Secretary, 2018), BNC would have a majority controlling equity 
interest of 65% and Spark would have an equity interest of 35% in the JV. The 
goal of this proposed transaction was to accelerate BNC’s strategy and 
strengthen its pharmaceutical and vaccine R&D business and pipelines. Within 
three years, this integration is expected to position the consumer healthcare 
business as a new world-leading over to counter (OTC) company. Ultimately, it 
is designed to lead BNC Consumer Healthcare business to become a 
separately traded public company. BNC Pharmaceuticals/Vaccines business will 
be another separate entity.  
 Before this announcement, BNC just bought a consumer healthcare JV 
for $11.5 billion from Galaxy, a Switzerland-based global healthcare company. 
This JV was formed in 2015 as part of the Galaxy portfolio transformation 
(Galaxy, Media Relations, 2015). The divestment was completed by August 
2018.  
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Background of the JV with Spark 
 Consumer healthcare products are dependent on customer loyalty and 
trademark protection. With heritage products and continuous innovation, BNC 
Consumer Healthcare has been the market leader in therapeutic oral health and 
pain relief for decades and has a strong brand loyalty with its targeted customers. 
It has a portfolio of flagship product brands including: Ignyte, Griner, Lullty, and 
Phace. As a result, over half of its annual sales can be generated from these two 
categories in major developed markets.  
 Spark has pioneered in introducing affordable consumer healthcare 
products to China and India, and has a strong performance in the emerging 
markets. It leads the category of pain relief and vitamin and mineral supplements 
in the markets. Its powerhouse brands include Champion, Nourishy and Azurer.  
 This proposed JV would leverage the power of both companies’ market 
and brand segmentation, which meant to create a world-leading consumer 
healthcare company. In this JV’s announcement, Kirby said:  
  “After the integration of BNC and Spark’s consumer healthcare 
businesses we will create greater further value for our shareholders. Meanwhile, 
incremental cashflows and visibility of the intended separation will help support 
BNC’s future capital planning and further investment in our pharmaceuticals.” 
(BNC, Company Secretary, 2018) 
 
Integration Guiding Principles 
 BNC had experience in consolidating market resources and had 
previously acquired several brands from other rivals before. But this JV with 
Spark, consolidating the whole business of another company, was 
unprecedented. Worldwide, BNC has 30,000 employees, 36 manufacturing sites, 
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and a business presence in over 100 markets. To move this big muscle around, 
complexity and uncertainty lay ahead.  
 An integration office was formed with experts from the legal, commercial, 
R&D and operations teams to manage the process. In every possible 
communication vehicle, this office iterated guiding principles of integration 
success. Three key messages are paraphrased as below.  
- Business continuity is the top priority.  
- Ensure an organized, transparent, and inclusive employee experience    
     with minimal disruption and maximum engagement. 
 
- Deliver the integration plans to minimize uncertainty, maximize  
     opportunities and deliver synergy commitment.  
 
 Bill Wheatley, the CEO of BNC Consumer Healthcare encouraged 
employees to be more courageous and accountable and involve fewer people in 
decision-making to facilitate this integration and make it happen within the 
targeted timeline.  
 In a highly regulated industry like healthcare, there is a primary tension 
between purpose and safety (Fried, 2017). Changes also need more time to 
adapt in the healthcare industry. Therefore, the agile approach (Berlin, Smet, & 
Sodini, 2017) to run experimental actions first was advocated widely within BNC 
Consumer Healthcare since the integration began.   
 
Learning Drives R&D Capabilities 
 As innovation and building a competitive product pipeline were priorities 
for BNC Consumer Healthcare, it had strived for the culture of learning, 
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particularly in R&D. In R&D, everyone lived with multidimensional learning to 
achieve continuous improvement.  
 The Consumer Healthcare R&D developed products in five categories: 
oral health, pain relief, respiratory, nutrition and digest health, and skincare. 
Besides the five category/business teams, R&D also had four functional teams 
focused on clinical development, regulatory, technical excellence and operations, 
and R&D innovation, respectively. This organizational structure (see Figure 1) 
had been considered in the re-organization since the beginning of the JV with 
Spark.  
A Culture of Continuous Learning  
 Among all R&D teams, the innovation team served as the bridge for 
external learning. This team consisted of subject matter experts (herein SMEs) 
across all business and functional teams. The team not only collaborated with 
Figure 1. R&D Organizational Structure (Tang, 2020) 
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traditional academic and research institutions but also reached out to diverse 
partners, like start-ups and investors. By doing so, it aimed to create novel 
solutions to tackle challenges in the Consumer Healthcare and seize market 
opportunities in a timely manner. In addition to that, it put some of the R&D 
needs on BNC’s official website to seek innovative ideas from the public. 
 Valuing external learning, the Consumer Healthcare R&D also had 
concrete internal learning processes (Garvin et al., 2008). Every R&D staff had a 
blend of informal and formal learning based on their roles. All R&D functional 
teams provided formal learning in their fields, respectively. For instance, the 
learning committee of the clinical development team brought knowledge of 
clinical research, development, and operations along with the foundation of 
toxicology and biostatics to the clinical workforce in R&D.  
 Within the TEX team, in 2015, a team named Capabilities, Learning, and 
Development (herein CLD) was created to provide job-role based customized 
training and expand organizational capabilities. The TEX team consisted of more 
than 850 scientists in the areas of analytics, formulation, prototyping, and 
packaging at the Consumer Healthcare R&D laboratories and pilot plants across 
all business teams. They worked in many countries and had a major presence at 
R&D sites in the US, UK, Switzerland, and India. Figure 2 illustrates the 
simplified TEX team structure. 
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The Role-Based Training Strategy  
 The CLD team focused on offering the right training for the right people at 
the right time. It partnered with both the business functional and quality teams to 
develop strategic training plans and governance for TEX to drive for the 
competency of learning and training compliance. The training plan incorporated 
on-demand learning needs, value-added learning, and development programs. It 
mainly delivered through myLearning, a learning management online system 
used companywide. Figure 3 illustrates the simplified workflow of how staff 
receive a learning plan.  
Figure 2. Simplified TEX Team Structure (Tang, 2020) 
Figure 3. Simplified Workflow of How Staff Receive A Learning Plan (Tang, 2020) 
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 After the CLD team and managers of each R&D sites defined the specific 
local training strategy, the CLD team took responsibility for assigning the training 
plan to each TEX staff’s myLearning folder. The learning plan was usually 
composed of core learning curricula required by local needs and job roles and 
optional (also called self-assigned) curricula. These curricula were authored by 
internal experts and approved by the quality advisory councils. 
 
Understanding the Project  
  “My father used to work at a major advertising company for many years. 
He told me questions that he often thought about before he dived into designing 
any marketing campaign for any client. These questions are: Who cares? What 
difference does it make? What is in it for its target audience?”  
- Vivian Lauder, BNC CH R&D Technical Training Manager 
 
 I had two rounds of interviews with Vivian and Dian Heimer, respectively. 
The conversation with Vivian focused on CLD team’s role and responsibility as 
well as my experience in project management and multiple-stakeholder 
coordination. Dian was on her second assignment from the Global Regulatory 
Affairs to the CLD team. When I talked with her, she first asked: “Have you 
worked in any highly regulated industry before?” I shared with Dian my short 
experience in a global fast consumer goods company and told her about some 
experience I had working with some standard operating procedures (herein 
SOPs). She laughed and responded, “Well, you’ll have a summer to know what 
a regulated industry looks like and what compliance really means.” Through 
these interviews, it became clearer that Dian would be the project manager I 
needed to work with directly. But I still had questions in mind. What is the 
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project really about? What will lead it to success?  
The Evolvement of Equipment and Process Related Training  
 In alignment with the quality requirements, TEX staff had been 
responsible for completing related equipment and process training (majority is 
SOPs) at a specific R&D lab/pilot plant before performing corresponding activity. 
It had been a part of TEX staff’s learning metrics and included in their 
performance review.  
 Such training was defined as a part of the core learning curricula with an 
established due date in 2016. It sounded rigorously ensuring that the TEX staff 
was doing the right thing. In reality, it was not received well. Each R&D lab/pilot 
plant had numerous pieces of equipment and each piece of equipment 
associated with at least one SOP. Considering this, it felt like completing all 
SOPs within limited time was like asking a student to read through all the books 
at the school library at once. It not only overloaded training to the staffs’ daily 
work, but also led to unknown learning behaviors and unpredictable outcomes.   
 With collective constructive feedback, in late 2017, the equipment and 
process related training was changed into self-assigned curricula. It was the 
same year as Dian started her second assignment away from the Global 
Regulatory Affairs. Shortly after she joined the CLD team, she identified the 
risks of assigning the equipment and process related training as the optional 
curricula. On one side, managers lost visibility of their subordinates’ training 
status as the self-assigned mode in myLearning did not reflect on learning 
metrics by default. On the other side, if any updates on SOPs are made, staff 
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would not receive automatic notifications to keep up with the latest required 
training. It is still caused by the same reason.  
 Simply put, it was hard to know whether TEX staff keep up their 
compliant training status or not in this self-assigned mode. This presents a 
potential compliance issue. As the culture of continuous improvement 
(Chandrasekaran and Toussaint, 2019) permeated in the Consumer Healthcare 
R&D, Dian initiated the project of implementing a digital tool to help TEX staff 
verify outstanding training needs for equipment and process. The original plan 
targeted at seven sites as following: A (US), B (US), C (UK), D (UK), E (UK),     
F (Switzerland), and G (India).  
 With a limited full-time staff and a large global audience to support on a 
daily basis, the CLD team was seeking additional talent to lead this project. That 
is how I came to my assignment. Though I joined the team as a summer 
graduate intern, I worked as a project leader.   
Getting Closer to the Project 
 As soon as I started my time at BNC, I realized that I needed to have a 
thorough understanding of the digital tool that Dian wanted me to implement. 
This digital tool, named Masterfinder, is a web application developed in the 
summer of 2017 by the Vaccine business. After months of internal system and 
quality validations, it had been put into use at the Vaccine manufacturing plants 
since late 2018. The purpose is to ensure staff has adequate training before 
performing a corresponding activity.  
 For example, if staff wanted to operate a certain type of laboratory 
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freezer or perform certain centrifuge process, they needed to verify that they 
had read the related latest SOPs. By inputting an employee ID number, the 
series number/barcode of that specific equipment/system, and its location area 
on the Masterfinder web page, they can check whether they had completed 
related training and fulfilled the compliant training status. At the back end, the 
Masterfinder was integrated with myLearning seamlessly. This enabled staffs’ 
learning records to be retrieved in real-time. Figure 4 illustrates the simplified 
workflow of how staff use Masterfinder.  
 After a couple of weeks of exploration, it became clear that this project 
was more than implementing a digital tool to the Consumer Healthcare R&D. It 
actually consisted of two parts. One was to configure Masterfinder to fit the 
Consumer Healthcare business at best. Another one was to transition all 
involved training materials from the self-assigned mode to the required mode 
without a due date set in myLearning. By doing so, equipment and process 
related training would be the required curricula. But setting it without a due date 
would also give learning autonomy back to the TEX staff.  
 Up to the time of need, TEX staff can check their equipment and process 
Figure 4. Simplified Workflow of How Staff Use Masterfinder (Tang, 2020) 
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training needs on Masterfinder first. With identified needs, they can complete 
related training on myLearning to maintain their compliant status. If related 
SOPs have version updates in the future, they will receive instant myLearning 
notification as the required curricula setting would provide such a function.  
 It sounded simple, but challenges lay ahead. 
Holding the “Adopt while Adapt” Mindset 
 Unlike the Vaccine manufacturing plants, the Consumer Healthcare 
laboratories and pilot plants were relatively smaller facilities and had various 
equipment ranging from small testing tubes to larger prototyping machines. Not 
all equipment had identifiable, marked series numbers. It did not mention that 
some small consumable equipment did not register in the equipment inventory 
at all. In addition, each site was designed differently to meet each country’s 
regulatory requirements for facilities. The reality of the situation made it 
impossible to categorize equipment and process related SOPs into specific 
physical area levels as the Vaccine business had achieved.  
 Also, making all involved training materials transition from the self-
assigned mode to the required without a due date on myLearning would take 
time. It is a manual process like identifying some books in a library and moving 
them from one shelf to another. During the transition, CLD team can make the 
primary differentiation between process related training materials and 
equipment related ones based on the title of SOPs. However, if it goes to a 
deeper level to associate each SOP with its related process or equipment, CLD 
team did not have such knowledge. Would such a level of association be 
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needed within TEX? If so, would there be SMEs from each site working with 
CLD team on the classification process?  
 While understanding this project, Dian proposed a potential second 
phase of the project, to implement Masterfinder’s newest barcode scanning 
feature. This new feature was designed to allow users to scan a barcode placed 
on or next to the equipment instead of inputting information manually. It can 
work on mobile devices under the Android and Microsoft environments. It was 
rolled out only to the Vaccine business.  
 Known and unknown coupled with each other. It’s undoubted that a new 
process and equipment learning solution was on the way. It also seemed a 
journey of double-loop learning: “doing the right things is far more important 
than doing things right.” (Argyris, 1996)  
 Questions kept on spinning in my mind. How to make Masterfinder the 
most effective to meet the needs of Consumer Healthcare R&D? To what 
extend can CLD team take control? Who should be engaged in this process? As 
the agile approach was widely advocated within the Consumer Healthcare, in 
what ways can it bring the most value?  
 
Leading the Efforts to Change  
  “I have lived in the breath of regulatory every day for decades. If you 
want to make changes here in pharma, you have to bring the regulatory and 
quality people on your side. Otherwise, nothing will happen.”  
- Dian Heimer, BNC CH R&D CLD Senior Manager 
 
 With the essential understanding of the project in hand, Dian began 
thinking of when and where to introduce this project. She deliberately scheduled 
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a half-hour time slot at the monthly Consumer Healthcare R&D global learning 
network meeting. Participants of this monthly meeting were leaders from the 
global and local quality and regulatory councils, related lab managers, and 
training managers from different functions. 
Be Prepared for the Process 
 Before the meeting, I had two weeks to prepare, including obtaining 
authorization for myLearning and Masterfinder and building the introduction 
presentation. Obtaining system access in other organizations I have worked 
before was not complicated. Sometimes, it just required a simple procedural 
application. However, that is not the case in such a highly regulated industry.  
 For myLearning, I had to allocate most of a week’s time to study 
intensively with the purpose of getting the manager level’s access. I passed the 
exam and broke the record of how fast a BNC staff can be certified to that level. 
At the same time, I worked closely with the system owner of Masterfinder, who 
worked for the Vaccine business in Switzerland, to have access to the system 
with administrative permission. Access to the backend of both systems enabled 
me to get closer to turning the initial project idea into reality. The key actions are 
summarized (see Figure 5).    
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 Moving forward to preparing the project introduction, Dian suggested that 
it is necessary to mention upfront that this soon-to-be implemented solution was 
validated by the Vaccine business. That should add credibility to the project, 
especially in front of key stakeholders from the quality and regulatory councils.  
  She was right. My introduction was soon interrupted by a senior quality 
director at the monthly meeting. He asked me, “Has Masterfinder been 
validated? How’s the track record of success?” After I emphasized it was fully 
validated and demonstrated some comparative user data that I collected from the 
Figure 5. Summary of Preparations before the Project Introduction (Tang, 2020) 
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Vaccine business, he seemed relaxed and showed interest in learning more. 
Toward the end of the presentation, I showed a recorded video demonstration of 
how to use Masterfinder and myLearning together to meet the goal of keeping 
equipment and process training compliant and efficient. The audience at the 
meeting showed allied support. Such sponsorship from the senior leaders 
provided the authority and credibility as the foundation of my further work.  
Determining Approach  
  With the success of the first project introduction, I was appraised by the 
CLD team and dedicated to driving introductions to site managers of the seven 
targeted locations. That weekend, I reached out to Dr. Russo and shared my 
thoughts about where I was and how I could better construct the upcoming 
introduction meetings. With her insightful inquiries, I realized that the essence of 
this project was a new learning solution as well as a change process. I asked   
Dr. Russo for her advice on what ways I should better lead the change 
management. She paused and said something memorable for me, “People often 
say ‘change management’. I see it as a navigation process. It’s more about 
navigating as change constantly happens.” Her thoughtful words intrigued me to 
spend time exploring some studies on change management.  
  I was influenced most by the “8-Step Change Model” offered by         
John Kotter and the “ADKAR” model by Jeffrey Hiatt. In the article of “Leading 
Change” published by Harvard Business Review (Kotter, 1995), John Kotter 
proposed the 8 steps as following:  
1. Establish a Sense of Urgency 
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2. Form a Powerful Guiding Coalition 
3. Create a Vision of Change 
4. Communicate the Vision of Change 
5. Empower Others 
6. Generate Short-Term Wins 
7. Sustain Acceleration 
8. Institute Change 
  This model places vision and coalition as the gateway to a successful 
change. Whereas, the ADKAR model (Hiatt, 2006) starts with the awareness of 
the need to change. ADKAR is an acronym for Awareness, Desire, Knowledge, 
Ability, and Reinforcement (2006, p. 2). Hiatt described the purpose of ADKAR:  
 The lifecycle for ADKAR begins after a change has been identified. From 
this starting point, the model provides a framework and sequence for managing 
the people side of change. In the workplace, ADKAR provides a solid foundation 
for manage management activities, including readiness assessments, 
sponsorship,  communications, coaching, training, recognition, and resistance 
management (2006, p. 3).  
 
 The success of the first introduction formed a powerful coalition (Kotter, 
1996). It was only the beginning of the process. Moving forward, I planned to use 
a tailored approach to construct upcoming introductions for site managers with 
two purposes. The first was to increase their awareness of the need to change. 
The second was to have their support and take part in the change, which can be 
seen as creating “Desire” (Hiatt, 2006) in the ADKAR model.  
 Dr. Russo also invited me to keep thinking of two questions: What can I 
control? What do I need from others involved in this project? Though I can make 
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the primary classification of equipment and process SOPs on the learning 
system, the local teams had to be part of the change journey and to be the 
change agents (Pascale & Sternin, 2005). A principal consideration is that each 
site can make sure whether the related equipment and process SOPs fall into the 
right curricula as expected by verifying the primary classification. In addition to 
that, each site can utilize the sub-area searching function on Masterfinder only if 
designated SMEs can work with CLD and advise the classification logic.  
 Put simply, more commitment from each site would create more value for 
the implementation. A clear project stakeholder map was shaped (see Figure 6).  
Figure 6. Project Stakeholder Map (Tang, 2020) 
Be Strategic for the Roll Out  
 Over next two weeks, I scheduled meetings with the seven initial targeted 
sites. Site managers and key influencers of each site were identified by Dian and 
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invited to each project introduction meeting. Together, we prioritized each site 
based on the urgency of the needs to change the equipment and process training 
and the complexity of local implementation. Dian also offered some previous 
change initiative experience with each site for our consideration. The targeted 
sites were categorized into three groups:  
1. Potential pilot sites: A (US), D (UK) 
2. Scale-up sites: F (Switzerland), G (India) 
3. Important but not urgent sites: B (US), C (UK), E (UK) 
 Three key elements of the project (see Figure 7) were framed into the 
introduction meetings with the hope to answer the question of “What’s in it for me 
(WIIFM)?” (Hiatt, 2006, p. 9)  
 Throughout the meetings, there were things that we hoped to see but also 
some unexpected learning. Site managers and SMEs from A and D showed their 
enthusiasm for participating as pilot programs. In terms of the general 
manufacturing plant (herein GMP) sites like F and G, there was local awareness 
and a desire to be part of this project. However, due to the site size, it would take 
Figure 7. Three Key Elements in Project Introduction (Tang, 2020) 
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more time for both sites to appoint appropriate contact persons and SMEs 
working with CLD team. At the other end of the spectrum, the manager at site E 
wanted to opt-out of this project because that site was too small, and all 
equipment and process training were requested to assign to TEX staff as part of 
the required onboarding procedure. For sites B and C, the JV put them in the 
spotlight as some TEX staffs’ work may be outsourced to vendors.  
 Assessing the readiness made me realize that this new learning solution, 
as well as the change process, had different meanings for each site. Clearly, one 
size did not fit all. The beauty and value of the assessment process made this 
project understandable and helped me to see each site’s situation and needs.  
 
Opening an Action Invitation 
  “Learn from the people, plan with the people…when the task is 
accomplished, the people will say, we have done it ourselves.”  
- Lao Tzu 
 
Implementing a project to make change happen in a large organization is 
a major undertaking. With the understanding from these meetings, Dian and I 
decided to run a pilot program to test, learn, and move forward. Site A was 
selected for three main reasons. First, the site manager demonstrated a strong 
interest in participation, which can be turned into further commitment. Second, 
the project success at the head office of Consumer Healthcare can be impactful 
for scale-up. Last but not least, it is easier to implement and collect feedback as I 
was based at this site.  
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Running the Pilot with New Perspectives 
 Once we made the decision, I started working on the curricula 
classification for site A and verified it with the site manager. Meanwhile, I initiated 
a pilot introduction meeting. I was also invited to present at the monthly R&D staff 
meeting. Scientists at the laboratory were the target audience for both meetings.  
 One day before the pilot introduction meeting, Elizabeth Watson, the CLD 
team director, stopped by my desk and asked me to show her the presentation. I 
ran through the presentation with an emphasis on how Masterfinder can help 
frontline scientists keep the training status compliant. She reminded me that the 
target audience was frontline scientists this time. “No other groups are like them. 
They enjoy trying new things and being part of a solution”, she said. Her 
comments were insightful. I asked myself how would I feel if someone wants me 
to try something that seems useful but sounds mandatory? It would feel like 
another top-down project and I might lose my intrinsic motivation to participate 
and learn at the beginning.  
 Most of the frontline scientists were well-educated with advanced degrees. 
That being said, they had accumulated judgment in learning and were 
enthusiastic about continuous improvement. I think the essence of Elizabeth’s 
comments was that I needed to invite them to be part of the solution rather than 
make them feel the solution was forced on them. I shifted my presentation 
approach from telling to inquiring. At the meeting the next day, I began by asking 
the onsite scientists two questions. What kinds of changes would they like to see 
in equipment and process training? Which change would they most like to have? 
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One person immediately shared her struggle with finding newly updated SOPs 
under the self-assigned mode. The introduction started off there and the 
audience was engaged in interactions.  
 After the meetings, all TEX staff at site A were invited to test the 
equipment and process training solution and provide real-time feedback. They 
needed to evaluate the necessity of the sub-area classification function. They 
were not provided with a well-designed Lego model but a prototype that they can 
build bricks on and create value.  
 Although this roll-out may look like the last step in the pilot program, it was 
at the beginning of the story. The mindset of continuous improvement and 
openness to feedback were the driving forces.  
The Importance of Timing  
 A few days after the pilot program launched, all staff at site A were invited 
to an offsite milestone event. BNC announced at the event that it had completed 
the JV transaction with Spark. In the press release Bill Wheatley said:  
  “Now the deal has completed. With our portfolio of exceptional, science-
driven brands and strong talent and capabilities, we are striving for creating a 
world-leading consumer healthcare business.” (BNC, Company Secretary, 2019) 
 
 During the following days, I barely heard any program feedback from 
frontline scientists. One reason was that the JV announcement made a different 
impact on them. Some seemed worried about potential layoffs due to the 
upcoming workforce integration. Some sounded excited about potential R&D 
projects. In either case, participating in this pilot program did not seem like a 
priority.  
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 Keeping the momentum of the pilot program going was imperative. Dian 
reminded me about deliverables with the constraint timeline. It was two weeks 
away from the end of my assignment; I would be leaving BNC.  
Bringing the Effort to Scale  
 To gain momentum, with the lab manager’s permission, I worked several 
afternoons at the laboratory. My physical presence made my connection with the 
frontline scientists closer. I got the chance to observe how they worked in the 
laboratory environment and contemplated how this solution can be calibrated to 
scale up. Scientists stopped at my desk to offer feedback and ask their 
questions. Some of them said they appreciated me being there as interpersonal 
communication can save time compared with the back and forth email 
exchanges.  
  While the pilot program was in progress, I started working on preparations 
to scale up. The first was to draft the SOP of Masterfinder. The SOP provided the 
procedure for using the Masterfinder application in Consumer Healthcare R&D to 
check incomplete training for laboratory equipment and processes. The second 
was to create a training slide with the introduction of the CLD training strategy 
first. It followed with the detailed instruction on how to use Masterfinder and 
myLearning together to keep the equipment and process training compliant. Last 
but not least, I began exploring the feasibility of Masterfinder’s barcode scanning 
function at Consumer Healthcare.  
 By the time I left BNC, the first two preparations were completed. Dian 
took over the rest of the project work. At my farewell lunch for me, she expressed 
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her great appreciation for all achievements and preparations I did for the project.  
 
Moving Forward 
 When I worked at BNC, every day of the 12 weeks was almost filled with 
meetings, coordination, planning, and deadlines. I was put on an accelerated 
track in extraordinary organizational circumstances. There were fulfilling 
moments as well as frustrations. Dr. Russo guided me through it and instilled 
the reflective learning mindset to my journey.   
 When I ruminate my summer experience, it feels like a capsule enriched 
by many layers and many colors. It can be seen and analyzed from many 
perspectives. Through the lens of influencing and persuasion, it taps into 
engaging with different levels of stakeholders and creating value to get their  
opt-in. From the organizational learning point of view, it is about an organization 
seeking continuous improvement. It is also a change management process with 
deliberate planning and starting from small steps, which is a core value of agile 
approaches.    
 As I write this capstone, I have realized that this case is not singular. 
Many organizations in pharma are confronted with similar challenges, to keep 
the backbone functioning while striving for continuous improvement and 
innovation. Meanwhile, I have come to realize that my education from the 
Organizational Dynamics Program at Penn, as well as my working experience, 
can bring enormous value to facilitate the process. It has shaped the innovative 
exploration of this capstone study.  
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CHAPTER 3 
LITERATURE REVIEW 
 
 My working experience at BNC in the summer of 2019, along with my 
current study in the Organizational Dynamics program, has inspired me to 
further explore the value of agility in building the learning capability in pharma. 
Building from the experiences of the case, the literature review is outlined and 
based on three major areas that serve my learning objectives.  
- Agility: What is agility? What makes it matter to pharma?   
- Change: What change management methodologies are most effective        
     to facilitate change initiatives in pharma? Do they contain agile    
     components?  
- Learning: What role does agility play in extending the focus from    
     individual learning to organizational learning? 
 The literature review includes, but is not limited to, industry research 
reports, academic articles, and books with broad theoretical and practical topics. 
It by no means serves as an exhaustive review of the vast amount of existing 
resources on the areas mentioned above. In addition to achieving my learning 
objectives, the literature review hopes to provide a novel bridging of agility, 
change, and learning and bringing clarity and potential minimizing the current 
research gap.  
 Each of these areas is analyzed in consideration of the BNC case. And 
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the case provides a real context to reflect and explore both theoretical and 
practical topics presented.   
 
The Rise of Agility 
 While agility may be the buzzword most often associated with startup and 
technology businesses, it is drawing attention in the pharma world. A Google 
search of the term “pharma agile” returned nearly seven million search results 
(Google.com, n.d.). The research results include R&D, supply chain, digital 
transformation, employee capability building, leadership, and beyond.  
 In a media interview, a senior marketing executive at GSK, a UK-based 
global healthcare company, describes how digital transformation helps the 
company move forward more efficiently and programmatically and further 
explains:  
Whereas we have some resources that we can invest into all sorts of 
ideas and we are learning how you call time on them if they're not going 
to work, because we know that 95% of new ideas fail. You have to set 
yourself up to not invest the whole business in those experiments, but 
instead have lots of experiments and pour gasoline on the ones that 
work. (Rogers, 2018) 
 
 In another executive interview conducted by McKinsey, a senior human 
resources executive at Roche, one of the world’s largest biotech companies, 
discusses the company’s agile transformation and emphasizes its preparation of 
its leaders to be more agile:  
In this dynamic environment, our ability to respond well to whatever 
happens requires a different approach and a more agile mindset, 
especially for our senior leaders across the organization…It is not just 
about delivering the business but also focusing specifically on people 
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leadership. (Lowry, Lurie, & Byrne, 2019) 
 
 Despite the company size and expertise, it seems executives at pharma 
are equipping their organizations with agile capabilities. So, what is agility? And 
what makes it matter to pharma?  
What is Agility? 
 Borrowed from Middle French and Latin, the word “agile” was first known 
to be used in the 14th century. It is defined as “having quickness of motion, 
nimble, active” (Etymology Dictionary, n.d.). And “agility” is defined similarly as 
“mobility, nimbleness, quickness” (Etymology Dictionary, n.d.). Agility is not in 
an immovable state, but an ongoing process, much like a continuous 
improvement (Harraf, Wanasika, Tate, & Talbott, 2015).  
 Agility is also defined as “the organizational capacity to effectively detect, 
assess and respond to environmental changes in ways that are purposeful, 
decisive, and grounded in the will to win.” (Tilman & Jacoby, 2019, p. 7), noted 
in the book “Agility: How to 
Navigate the Unknown and 
Seize Opportunity in a World of 
Disruption.” The authors of this 
book believe agility is an 
overarching quality that can 
prepare organizations to go 
much further in their domains. 
They describe agility’s distinctive nature (see Figure 8).  
Figure 8. Agility: An Overarching Quality   
(Tilman & Jacoby, 2019, p. 48) 
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 At the basic level, agility has two distinct parts: flexibility and adaptability 
(Harraf et al., 2015). It does not  mean organizations have to trade stability for 
flexibility and adaptability. A 2015 Mckinsey report highlights that agility rhymes 
with stability, “truly agile organizations, paradoxically, learn to be both stable 
(resilient, reliable, and efficient) and dynamic (fast, nimble, and adaptive).” 
(Aghina, Smet, & Weerda, 2015) The authors of this report highlight that 
balancing the tension between stability and flexibility is critical.  
To master this paradox, companies must design structures, governance 
arrangements, and processes with a relatively unchanging set of core 
elements-a fixed backbone. At the same time, they must also create 
looser, more dynamic elements (capability) that can be adapted quickly 
to new challenges and opportunities. (Aghina et al., 2015) 
 
 A similar perspective is also offered by David Teece, Professor of Global 
Business of University of California, Berkeley in a 2016 article published in the 
California Management Review. He and his colleagues further categorize 
dynamic capabilities into three primary clusters.  
-   identification, development, co-development, and assessment of    
     technological opportunities (and threats) in relationship to customer   
     needs (the “sensing” of unknown futures);  
-   mobilization of resources to address needs and opportunities and    
     capture value from doing so (“seizing”); and 
-   continued renewal (“transforming” or “shifting”).  
     (Teece, et al., 2016, p. 6) 
 
 Despite different focuses on agility, most studies and researchers 
acknowledge that the global economy is experiencing innovation and complexity 
more than ever. And the globalized competition and competitive intensity 
(Harraf, et al., 2015) drive organizations to become agile to respond to market 
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changes promptly.  
History at a Glance 
 As the words agile, agility, and many related words get attention, it is a 
common assumption that agility stems from software development, where most 
agile successful stories seem to be known. As a matter of fact, the origin of 
agility is rooted in the manufacturing industry (Harraf, et al., 2015) where 
changes in the product development and supply chain require both adaptability 
and flexibility. The history of agility and agile manufacturing comes from that of 
LEAN manufacturing (Marchwinski & Shook, 2007). Taking a look back at 
history, several studies are the cornerstone for exploring the evolvement of 
agility.  
 In January 1986, Hirotake Takeuchi, Professor in the Strategy Unit at 
Harvard Business School and his colleague Ikujiro Nonaka published an article, 
“The New New Product Development Game” in the Harvard Business Review. 
With years of study of multinational companies such as Fuji-Xerox, Canon, 
Honda, NEC, Epson, Brother, 3M, Xerox, and Hewlett-Packard, they pointed out 
that the successes of these companies are mainly attributed to an overlapping 
development process, the “rugby approach” (Takeuchi & Nonaka, 1986), rather 
than the older sequential approach. They provide an illustration (see Figure 9) 
and further explain: 
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This new emphasis on speed and flexibility calls for a different approach 
for managing new product development…The shift from a linear to an 
integrated approach encourages trial and error and challenges the status 
quo. It stimulates new kinds of learning and thinking within the 
organization at different levels and functions… The energy and 
motivation the effort produces can spread throughout the big company 
and begin to break down some of the rigidities that have set in over time. 
(Takeuchi & Nonaka, 1986) 
 
They decided to call this cross-functional team and multi-disciplinary process as 
the Scrum (Takeuchi & Nonaka, 1986) project management.  
 This article attracted attention since it was published, and its significance 
was amplified in software development in the early 1990s by Ken Schwaber and 
Jeff Sutherland. They worked together and tested the Scrum framework (Scrum 
Alliance, n.d.), a lightweight, iterative, and incremental framework for managing 
complex work. With continued improvement, they joined with 15 developers and 
built the Agile Manifesto (Agile Manifesto, n.d.) in 2001. Some principles behind 
the Agile Manifesto are stated:  
- Welcome changing requirements, even late in development. Agile           
    processes harness change for the customer's competitive advantage. 
- The most efficient and effective method of conveying information to   
Figure 9. Sequential (A) vs. Overlapping (B and C) Phases of Development 
(Takeuchi & Nonaka, 1986) 
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    and within a development team is face-to-face conversation. 
- Agile processes promote sustainable development. The sponsors, 
developers, and users should be able to maintain a constant pace         
indefinitely. 
- The best architectures, requirements, and designs emerge from self-       
     organizing teams. 
- At regular intervals, the team reflects on how to become more  
     effective, then tunes and adjusts its behavior accordingly.                    
     (Agile Manifesto, n.d.) 
 
“If you think about the fundamental principles of the Agile Manifesto, the core is 
that ability for speed and efficiency.” (McCall, Sarrazin, & London, 2018, p. 2) 
It’s about breaking things into increments and making sure value is delivered 
each time.  
 Since 2002, agile methods have permeated software development. As 
the agile methods are based on customer collaboration, teamwork, iterative 
development, and adaptability, studies show both tangible and intangible 
benefits can be generated. “On average, agile methods are about 25 times 
more efficient than traditional methods.” (Rico, Sayani, & Sone, 2018, p. 128). 
The net benefits of agile methods can be calculated in cost and quality metrics, 
models, and measurements.  
Embracing Agile in Pharma 
 Though first adopted in the software development world, over time agile 
methods have spread across a broad set of industries and functions. In a 2016 
Harvard Business Review article, Takeuchi, Sone, and Sutherland stated that 
“the spread of agile raises intriguing possibilities.” (p. 42) Living in a dynamic 
and global environment, organizations confront constant changes more than 
ever and need to respond swiftly. They further explain the right conditions for 
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agile (see Figure 10) and emphasize that “innovation is what agile is all about.” 
(Takeuchi et al, 2016. p. 42) 
 The healthcare sector strives for solving complex life-science problems; it 
is where innovation often incubates. In the article, “Innovation in Health Care: A 
Primer” published in the American Journal of Medical Quality, the authors point 
out that the need for innovation is critical to enhance the quality of care (Varkey, 
Horne, & Bennet, 2008). They elucidate three types of innovation in the 
healthcare: product, process, and structure. The product includes whatever 
pharma companies and life science organizations can provide. The process is 
more about innovation offered by the care providers, like telemedicine and 
digital imagining. And the structural innovation relates to the health business 
model.  
Figure 10. The Right Conditions for Agile (Takeuchi et al, 2016, p. 46) 
  
45 
 As one of the innovation pillars in healthcare, pharma companies have 
realized the immense value that agility can bring, especially in building 
organizational capability and continuous improvement to enable innovation 
(Mahadevan et al., 2019). It is also believed that innovation leads to competitive 
advantages; studies show that being fast to market and product sales are highly 
correlated in pharma (Grabowski & Vernon, 1990; Roberts, 1999). In addition, in 
a highly regulated industry like pharma, “there are clearly industry rules that 
need to be followed and laws to be aware of.” (Fried, 2017). The primary tension 
between purpose and safety makes instilling dynamic capabilities (Teece, et al., 
2016, p. 6) in pharma a delicate process. And not to mention that agile ways of 
working can deliver value in multiple contexts through experimentation, 
digitization, and cross-functional teams (Srikant, Freeland, Lopez, & Greber, 
2019).  
 For a long time, R&D has been considered as the innovation engine at 
pharma. Given the capital-intensive and process-rigorous nature of pharma 
R&D, R&D productivity is continuously examined (Berggren, Fleming, Keane, & 
Moss, 2018). In the 2019 Harvard Business Review article “Why Science-Driven 
Companies Should Use Agile”, the authors highlight the emergence of “agile 
science:  a new way of working characterized by pragmatic and context-specific 
use of agile methods and tools.” (Fiore, West, & Segnalini, 2019, p. 3) With real 
case studies, they point out the importance of cross-functional teams and 
prototype testing in increasing pharma R&D productivity. They further outline an 
action framework and emphasize that it is critical to communicate the “why” of 
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the change to agile rather than just tell people “what” to do. In addition to that, 
they pivot to a point that “learning and adapting is, after all, at the heart of what 
science is all about.” (Fiore, et al., 2019, p. 5) 
 Adopting agile in any organization is a process. It comes with an extra 
layer of complexity in pharma R&D due to the science-driven nature as well as 
the risk-adverse mind-sets. In the McKinsey report “Designing an Agile 
Transformation in Pharma R&D” (Apple, Keane, Moss, & Sartori, 2019), the 
authors expressly point out that R&D staff tend to have habitual ways of doing 
things that are rigid and sequential, which may make them less willing to adopt 
the agile model until its benefits start to materialize. To unlock the value of agile 
in pharma R&D, the authors further offer an approach called “aspire, design, 
pilot, and scale-and-improve” (Apple, et al., 2019). It starts from a top-team 
aspiration and soliciting earlier stakeholder input to set the shared agile vision. 
Then design-thinking is suggested to be used to reimagine key processes and 
resource allocation. Conducting a pilot follows with a goal to create success 
stories as well as identify improvement opportunities.  
 Put simply, embracing agile in pharma needs both top-down vision and 
bottom-up support within organizations.  
 
Navigating the Change Process 
“Everything flows, nothing stands still.” 
- Heraclitus  
 
  “The only thing constant is change.” written by Heraclitus, an ancient 
Greek philosopher, back in 500 BC. A similar perspective is offered by Robert 
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H. Schaffer, an educator and management consultant, who believes “change 
never occurs as some sort of happening; it is part of everyday life.” (2017, p. 3) 
He advocates that leaders see change as the most important essence of the 
management job rather than an occasional disruptor. “Change management is 
management, and all management is change management.” (2017, p. 4)  
 Change is not always easy. It seems even harder in a highly regulated 
industry as pharma where change has to balance with safety and quality 
(Bhandola, 2015, p. 64). For organizations that want to stay competitive, an 
accelerated change environment can be created, like the integration presented 
in the BNC case. From the operation level, the BNC case can be summarized 
as implementing a training solution for continuous improvement with agile 
principles as guidance. Implementing something is not an event, it is a process. 
A process can only proceed with changes at multiple fronts. So, it is critical to 
have an understanding of change management.  
 Although there are many studies and models of change management, 
some of them are deliberately chosen here in consideration of both the macro 
context and the micro-processes presented in the BNC case. The expectation is 
to explore effective interventions to facilitate change initiatives in pharma while 
minimizing resistance to change from the people side.  
Paths of Realizing Change 
 As summarized in the first part of this literature review, change with agile 
components in pharma is not fully top-down or bottom-up. It needs elements 
from both. Thus, two change models are reviewed accordingly next.  
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 John Kotter, Professor Emeritus of Leadership at Harvard Business 
School, has been known as an expert on the topics of leadership and change. 
In his 1995 Harvard Business Review article “Leading Change: Why 
Transformation Efforts Fail”, he reflects on his decade-long observation of 
different change initiatives that happened across industries. He points out that 
from the more successful change cases, the most general lesson to be learned 
is that “the change process goes through a series of phases that, in total, 
usually require a considerable length of time.” (Kotter, 1995. p. 59). He further 
develops the “8-Step Process for Leading Change” (see Figure 11).  
 
    
 This process starts with creating a climate for change, which includes 
three steps: establishing a sense of urgency, forming a powerful guiding 
coalition, and creating a vision (Kotter, 1995. p. 61). Building urgency for 
change is about identifying and focusing on a window of opportunity that can 
Figure 11. Kotter’s 8-Step Process for Leading Change (1995) 
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further align people together. The guiding coalition is seen as the nerve center 
of the 8-Step Process (Kotter, 2018, p. 13). It is about assembling a group with 
enough power to lead and accelerate the change efforts. In pharma, despite the 
varied nature of change, quality assurance and regulatory affairs can be seen 
as the guiding coalition as they are the most important members to evaluate and 
endorse change (Bhandola, 2015, p. 64). Kotter (1995) also emphasizes the 
importance of defining a clear vision of the aim of the change. From his 
perspective, if a vision cannot be communicated clearly to someone in five 
minutes or less, it is challenging to have fast enough actions from frontline 
employees.  
 The next three steps of this process are about empowering actions from 
a broad-based level to make change happen. He highlights that “action is 
essential, both to empower others and maintain the credibility of the change 
efforts as a whole.” (Kotter, 1995, p. 65). As successful change often takes time 
in organizations, it is critical to create visible short wins, like an improved 
process and a new behavior, to acknowledge the change progress as well as to 
boost the credibility of the renewal process. In agile project management, the 
short wins can be considered as the success of pilots (Cohn, 2009, p. 82).  
 Moving forward with small wins, it is important to consolidate 
improvement opportunities to further fuel the change and stay the course of 
change over time. Kotter (1995) anchors the last step of the process in 
integrating the change into the organizational culture. He articulates that 
“change sticks when it becomes ‘the way we do things around here’…until new 
  
50 
behaviors are rooted in social norms and shared value, they are subject to 
degradation as soon as the pressure for change is removed.” (1995, p. 67) 
 Kotter’s 8-Steps Process has been seen as one of the first models that 
focuses less on change itself and more on the people side of the change. 
Though more than two decades passed since its first release, this model 
continues to have a definitive impact. While this model incorporates collaborative 
steps, it emphasizes the importance of leadership and is often considered as a 
top-down approach for leading change.  
 By contrast, the “ADKAR” model (see Figure 12) is a bottom-up approach 
with a focus on the individuals behind the change. It is created by Jeff Hiatt, the 
founder of the Change Management Learning Center in 2006 with the goal of 
guiding both individual and organizational changes. ADKAR is an acronym that 
represents five elements for realizing a change.  
 
 
 
 
 
 
 
 
 
 
 
Figure 12. The ADKAR Model (Hiatt, 2006) 
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 Hiatt outlines this model considering “the natural order of how one person 
experiences change” (Hiatt, 2006, p. 2). In the ADKAR model, change starts with 
an awareness that the status quo is no longer desirable. Building such 
awareness requires the following questions to be addressed.  
- What is the nature of the change and how does the change align with    
    the vision of the organization?  
- Why is the change being made and what are the risks of not   
     changing?  
- How will the change impact our organization or our community?  
- What’s in it for me (WIIFM)? (Hiatt, 2006, p. 9) 
 
 The awareness-building enables people to start the process of evaluating 
a change and hopes to trigger the desire to engage in the change. Hiatt (2006) 
elucidates four following factors that contribute to an individual’s or organization’s 
desire to engage in change. 
- Factor 1: The nature of the change (what the change is and how it will  
    impact them) 
- Factor 2: The organizational or environmental context for the change    
    (their perception of the organization) 
- Factor 3: An individual’s personal situation  
- Factor 4: What motivates them (those intrinsic motivators that are    
unique to an individual) (Hiatt, 2006, p. 18)  
 
 With established awareness and triggered desire, it now moves into 
knowledge, the third element of the ADKAR model. Knowledge is about to make 
sure people know how the change will be realized. Our current knowledge level, 
our capacity to learn, the availability of resources, and the access to needed 
information are considered as important factors (Hiatt, 2006, p. 27).  
 “Awareness, desire, and knowledge are all essential building blocks, but 
fall short of realizing change if ability is absent.” (Hiatt, 2006, p. 31-32). Ability, 
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the fourth element of the ADKAR model, emphasizes the capability to implement 
the change and achieve the desired goal. This model ends up with 
reinforcement, which includes any action or event that can sustain the change 
and keep people away from old behaviors or old ways of doing work. Hiatt (2006) 
emphasizes that reinforcement is successful when:  
- They are meaningful to the person recognized. 
- They are associated with actual accomplishments.  
- There is an absence of negative consequences for desired behavior. 
- Accountability mechanisms are in place. (Hiatt, 2006, p. 41)  
 
The bottom-up and people-centric attributes make the ADKAR model 
distinct from other change models. Such focus on individual efforts behind the 
change is also shared by the “Positive Deviance Approach to Change” (Pascale 
& Sternin, 2005) in different ways. This approach is recommended to work best 
when major behavioral and attitudinal changes are required in the change 
process. Richard T. Pascale and Jerry Sternin, professors from Oxford University 
and Tufts University respectively, co-coined this approach in their 2005 Harvard 
Business Review article, “Your Company’s Secret Change Agents”. They believe 
that people in organizations are “indigenous sources of change” (Pascale & 
Sternin, 2005, p. 75). And they advocate that leadership in the change progress 
needs to be positioned as inquiry and facilitation, which is seen as the key to 
engage people throughout the process. Moreover, they articulate this approach 
as below.    
- The positive deviance approach to change, by contrast, is bottom-up,   
inside out, and asset based. It powers change from within by  
    identifying and leveraging innovators. (Pascale & Sternin, 2005, p. 75) 
- The positive deviance approach to change requires a role reversal in  
  
53 
which experts become learners, teachers become students, and    
leaders become followers. Leaders must relinquish to the community 
the job of discoverer. (Pascale & Sternin, 2005, p. 81) 
 
 The essence of the positive deviance approach is captured by the 
Chinese Taoist sage Lao Tzu as Pascale and Sternin encapsulate at the end of 
the article.   
Learn from the people 
Plan with the people 
Begin with what they have 
Build on what they know 
Of the best leaders 
When the task is accomplished 
The people all remark  
We have done it ourselves (Pascale & Sternin, 2005, p. 81) 
 
 It is aligned with some perspectives offered in the book “Strategic Doing: 
Ten Skills for Agile Leadership” (Morrison, Hutcheson, Nilsen, Fadden, & 
Franklin, 2019). Authors of this book iterate that agile leaders need to make sure 
each member of a group shares the responsibility for implementation. Leadership 
does not reside in a single person in the group, but rather is shared by members 
of the group. And such shared leadership can give flexibility for the group when it 
is confronted with complex, strategic issues. They further provide some 
suggestions for cultivating an organizational culture of shared leadership.  
- Give power away to individuals to allow them to strengthen the 
    abilities.  
- Define clear boundaries for the decisions they are empowered to  
    make.  
- Give people the discretion and autonomy they need to complete tasks   
    and deploy their resources.  
- Managers should consider themselves a resource rather than a   
    supervisor.  
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- Set up an agile, iterative process that allow for regular check-ins to  
    review progress and make adjustments if necessary.  
(Morrison et al, 2019, p. 118) 
 
 Shared leadership seeks small commitments from individuals. This can 
move change forward agilely in the group. Change agility also requires leaders 
“to ask ‘why not?’ and to establish opportunities for pilots, prototypes, and 
experimentation” (Onderick-Harvey, 2018).   
Reactions to Change 
 Knowing different change management approaches is like building a 
toolbox. Yet, such knowledge needs to be tested in different contexts just as 
doctors perform the same procedure on different individuals. Reactions for 
change come in various forms, typically like acceptance, avoidance, and 
resistance (Wittig, 2012). 
 Change is intensely personal (Duck, 1993, p. 109). Change is 
fundamentally about feelings (Smollan & Sayers, 2009). The most successful 
change programs reveal that organizations connect with their people most 
directly through values – and those values ultimately are both beliefs and 
feelings (Duck, 1993, p. 109).  A model often referred as the “Four Rooms of 
Change Model” or the “Change House Model” provides a novel perspective to 
see reactions coupled with emotions in the change. This model was created by 
Claes Janssen, a Swedish psychologist, in 1970s as part of his research on the 
dynamics of change (Cook, 2012).  
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 The model proposes four frames of mind seen as rooms in an apartment 
as in Figure 13. The underlying assumption of this model is that change is a 
cyclical process involving 
different frames of mind, each 
with different emotions. And 
managing the change process     
requires that individuals 
acknowledge the emotions of 
each room. 
 In the “Contentment” room, individuals are satisfied with the status quo 
and no change seems desired. There is a sense of being relaxed. However, 
when change emerges, individuals may begin to worry that the change will 
negatively impact them in some way. It leads them to the “Denial” room, where 
there is a focus on defending the status quo. Ultimately, individuals have to 
acknowledge that change is about to happen no matter how they feel. In 
addition, they have to make the psychological transition from “It won’t happen 
here” to “Where is it going to happen?” (Baruch & Hind, 1999).  
 Moving forward the next room is coupled with ambiguity and it is aptly 
titled the “Confusion” room. Individuals may begin putting puzzles of the change 
together and explore options for realizing change, which may feel like an 
overwhelming process. Finally, individuals push through into the “Renewal” 
room, where they are committed to the change. This room fuels with positive 
energy towards change (Janssen, 2011).   
Figure 13. Four Rooms of Change Model       
(Janssen, 2011) 
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 While we are standing at different rooms in front of the change, 
sometimes our emotions are easy to be perceived. What might seem like a 
conundrum is the resistance to change in various behavior forms. Robert Kegan 
and Lisa Lahey are two Harvard professors of adult learning and experts in 
organizational psychology. Their work, Immunity to Change, reveals a 
psychological dynamic called the “competing commitment” behind the change-
resistant behavior with an insightful conclusion.  
Resistance to change does not reflect opposition, nor is it merely a 
result of inertia. Instead, even as they hold a sincere commitment to 
change, many people are unwittingly applying productive energy toward 
a hidden competing commitment. The resulting dynamic equilibrium 
stalls the effort in what looks like resistance but is in fact a kind of 
personal immunity to change. (Kegan & Lahey, 2001, p. 85) 
 
 Kegan and Lahey (2001) highlight that competing commitments are very 
personal and tapping into vulnerabilities that people fear, which are sometimes 
a result of self-protection. Underneath the self-protection is “big assumptions”, 
which is deeply rooted in our beliefs about ourselves and the world around us 
and is driving our behaviors away from realizing the change. They further offer a 
process framework of unfolding the immunity to change (see Figure 14). The 
process is to “help people cope with the inner conflict that is preventing them 
from achieving their goals” (2001, p. 92) 
 
Figure 14. A Diagnostic Test for Immunity to Change (Kegan & Lahey, 2001) 
  
57 
 The process starts with understanding why people behave in ways that 
undermine their own success. Several facilitative questions to get there are 
provided.   
- What would you like to see changed at work, so that you could be   
    more effective or so that work would be more satisfying?  
- What commitments does your complaint imply?  
- What are you doing, or not doing, that is keeping your commitment  
      from being more fully realized? (Kegan & Lahey, 2001, p. 87) 
 
Moving forward is to invite people to envision the consequences of the behavior. 
An example question is, “If you imagine doing the opposite of the undermining 
behavior, do you detect in yourself any discomfort, worry, or vague fear?” 
(Kegan & Lahey, 2001, p. 88) The next step is to transform that passive fear into 
a statement that indicates a commitment to prohibiting certain outcomes. The 
last step is to examine the big assumptions that hold commitment back. Often, it 
does not uncover all at once as we may accept the assumptions as reality, or 
the uncovering makes us uncomfortable.  
 Once the competing commitments and big assumptions are identified, 
Kegan and Lahey (2001) suggest people prepare to take action to overcome the 
change-resistant behavior.  
 
Learning in Organization 
  “We now accept the fact that learning is a lifelong process of keeping 
abreast of change. And the most pressing task is to teach people how to learn.” 
- Peter Drucker 
 
 The dictionary definition of learning states that learning is “knowledge or 
skill acquired by instruction or study” and “modification of a behavioral tendency 
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by experience” (Merriam-Webster Dictionary, n.d.). Argyris and Schön (1996) 
assert that learning occurs only when knowledge is translated into different 
behavior that is replicable. There are two important elements of learning: what 
people learn (know-how) and how people understand and apply that learning 
(know-why) (Kim, 1993).  
 “Human beings are designed for learning.” (Senge, 1990) In an 
environment where the only certainty is uncertainty, the one source of a lasting 
competitive advantage is learning (Nonaka, 1991). Takeuchi and Nonaka (1986) 
argue that the essence of agile is learning and has two dimensions: across 
levels (multilevel learning) and across functions (multifunctional learning).  
 All individuals as well as all organizations learn. Organizations ultimately 
learn from their individual members. Meanwhile, individuals are influenced by 
organizations to learn (Kim, 1993). Numerous studies show that learning needs 
effort from both the individual and organizational levels. It is just like growing a 
tree, which needs the right soil and the ability to adapt to various weather 
conditions. Considering the learning objectives of this capstone, I focus next on 
learning related studies in two aspects: individual learning at work and 
organizational learning. Some neuroscience studies serve as the foundation.  
Adult Learning with Two Minds 
 Learning is defined as a change in long-term memory and works as a key 
to realizing the principles of andragogy (Hagen & Park, 2016). In 1980s, 
Malcolm Shepherd Knowles coined andragogy as “the art and science of 
helping adults learn” (Knowles, 1980, p. 43) and pioneered studies in this area. 
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Knowles (1980) defined four assumptions of adult learners. In 1984, he added 
an additional assumption.  
1. Adults have a self-directed self-concept; 
2. Adults bring a growing reservoir of experience to the learning 
       process; 
3. Adults enter the learning process ready to learn relevant information;  
4. Adults are gravitated toward immediate application of learning; 
5. Adults are driven by intrinsic motivation to learn. 
 
Based on these assumptions of adult learners, Knowles (1984) suggests four 
principles of adult learning as following.  
1. Adults need to be involved in the planning and evaluation of their    
       instruction.  
2. Experience, including mistakes, provides the basis for the learning 
       activities.  
3. Adults are most interested in learning subjects that have immediate     
       relevance and impact on their job or personal life.  
4. Adult learning is problem-centered rather than content-oriented.  
       (Kearsley, 2010) 
 
Further study in the field of neuroscience shows that learning generates 
physiological changes in the brain, which is important to the notion of plasticity 
(Posner & Robarth, 2005). In a recent study, Hagen and Park (2016) provide an 
integrative analysis of why and how andragogy works through the lens of 
cognitive neuroscience. After reviewing a great deal of research, they pinpoint 
that adult learning involves major processing occurring in the brain, which 
requires interactions among multiple brain areas. Based on the findings, they 
provide a model (see Figure 15) that bridges the adult learning theories and 
cognitive neuroscience and further offers some educational techniques to 
facilitate the learning experience.   
  
60 
 In this model, Hagen and Park (2016) illustrate that the self-directness, 
the relevance of learning experience,  and the application of learning (Knowles, 
1984) are heavily connected to the prefrontal region of the brain, where 
supports higher executive functions and is particularly well developed in humans 
(MacLean, 1978; Rock, 2008).  
 Knowles (1984) highlights that adults learn best when learning is 
connected to a social role. Moreover, the need for social connection and 
acceptance is a strong psychological basis for adult learning. Hagen and Park’s 
model (2016) confirms this with strong biological evidence. Through studies, 
Hagen and Park (2016) find that when learning is relevant to adults’ social roles, 
the hippocampus and the anterior cingulate cortex are activated. Hippocampus 
Figure 15. A Model of Adaptive Cognitive Neuroscience - Adult Learning Structure 
(Hagen & Park, 2016, p. 183) 
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is the area where prior experience resides and can encode the emotional 
context from the amygdala, particularly fear and stress-related defensive 
responses (Blakemore & Frith, 2005). And the anterior cingulate cortex involves 
certain cognitive functions, like error detection, anticipation of tasks, and pain 
derived from social situations (Eisenberger & Lieberman, 2004). From the brain 
evolution perspective, hippocampus and anterior cingulate cortex are 
considered as important parts of the mammalian social brain (MacLean,1978; 
Rock, 2008).  
 In short, when adults learn with social roles, like in the workplace, both 
the prefrontal human brain and the social mammalian brain are in active state.  
What Keeps Us from Learning? 
 For years, the common assumption is that getting people to learn at work 
is mainly driven by a matter of motivation. When rewards are in place and 
people have the right attitudes and commitment, learning should automatically 
follow (Argyris, 1991). Various studies in the field of social psychology show that 
extrinsic motivation may change people’s behavior temporarily. However, a 
lasting commitment can only be achieved by intrinsic motivation (Kohn, 2018).  
 Knowles (1984) asserts that adults come to the learning process with a 
wealth of experience. It is widely accepted that adults learn better when they are 
encouraged to apply prior knowledge to new learnings. Interestingly, it has been 
argued that prior experience can also play a demotivator role in learning if adults 
have negative emotions associated with it. To address this, problem-based 
learning and experiential learning are broadly advocated (Kearsley, 2010).  
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 Chris Argyris, a former Professor Emeritus at Harvard Business School, 
found that every company faces a learning dilemma: the smartest people find it 
hardest to learn (1991). In “Teaching Smart People How to Learn”, published in 
Harvard Business Review, Argyris points out:  
Highly skilled professionals are frequently very good at single-loop 
learning. After all, they have spent much of their lives acquiring 
academic credentials, mastering one or a number of intellectual 
disciplines, and applying those disciplines to solve real-world problems. 
But ironically, this very fact helps explain why professionals are often so 
bad at double-loop learning. (Argyris, 1991, p. 100)  
 
The single-loop learning is about problem-solving (know-what). Whereas, the 
double-looping learning is more than just fixing the problem and involves 
questioning the underlying assumptions, values, and beliefs behind what we do 
(know-why) (Argyris, 1977). Because many professionals are almost always 
successful at what they do, they barely have experience with failure. So, when 
their single-loop learning strategies go wrong, they become defensive, which 
affects their cognitive reasoning ability. Eventually, defensive reasoning can 
block learning (Argyris, 1991).  
 Edgar Schein, a former professor at MIT Sloan School of Management, 
indicates that anxiety can also inhibit learning (2002). Through studies, he found 
that there are two kinds of anxiety associated with learning: “learning anxiety” 
and “survival anxiety”.  
The learning anxiety comes from being afraid to try something new for 
fear that it will be too difficult, that we will look stupid in the attempt, or 
that we will have to part from old habits that have worked for us in the 
past. Learning something new can cast us as the deviant in the groups 
we belong to. It can threaten our self-esteem and, in extreme cases, 
even our identity…Survival anxiety-the horrible realization that in order 
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to make it, you’re going to have to change. (Schein, 2002, p. 104). 
 
He further explains that learning becomes possible when survival anxiety is 
greater than learning anxiety. It can also be interpreted as people’s anxieties 
contributing to their resistance to learning.  
 On the surface, it appears that professionals shy away from using 
different behaviors while learning. From the cognitive neuroscience point of 
view, the social mammalian brain is heavily activated in negative emotions, like 
defensive or anxious situations (MacLean,1978). When the mammalian brain 
takes over the prefrontal human brain, higher intellectual functions, like learning 
and making decisions, tend to shut down. Or in the words of Argyris, 
“professionals’ ability to learn shuts down precisely at the moment they need it 
the most.” (1991, p. 100)  
Learning to Learn 
 Effective double-loop learning is not only simply a function of how people 
feel but also a reflection of how they think (Argyris, 1977). Knowles (1984) also 
believes that adults need to know the reason for learning something. To have 
effective double-loop learning, Argyris (1991) underscores the importance of 
teaching people how to reason about their behavior in new and more effective 
ways, which lays the groundwork for continuous improvement that is truly 
continuous.  
 To break down defensive reasoning and avoid embarrassment, Argyris 
(1991) offers four basic values behind designing one’s actions.  
1. To remain in unilateral control;  
2. To maximize “winning” and minimize “losing”;  
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3. To suppress negative feelings; and  
4. To be as “rational” as possible, meaning that people define clear    
       objectives and evaluate their behavior in terms of whether or not  
       they have achieved them. (Argyris, 1991, p. 103) 
 
 Feeling vulnerable and incompetent are typical sources of defensive 
reasoning (Argyris, 1991). We are taught to play to our strengths most of the 
time. So, the idea of learning something new, particularly not applying our 
frequently used strengths, can make us feel uncomfortable and vulnerable 
(Argyris, 1991; Edmondson, 1999). Such discomfort can be exacerbated when 
we learn slower than we expect and even make mistakes at the beginning. 
Interestingly, social cognitive studies find that when people are encouraged to 
expect mistakes and learn from them early in the process of acquiring new 
skills, the learning interests are heightened and better performance comes 
along (Woods & Bandura, 1989). Other researchers suggest that if we shift our 
focus from negative feelings to benefits associated with learning, we are more 
likely to learn initially unappealing things (Andersen, 2016).   
 Our desire to know and to experience is often driven by curiosity. Peter 
Senge (1990), the founding chair of the Society for Organizational Learning at 
MIT, highlights the significance of mobilizing the intellectual capacity of 
individuals in the organization, in other words, getting individuals curious, 
learning, and acting within all levels of the organization. Many studies reveal 
that the nature of curiosity as an emotional-motivational state is in a positive 
correlation with the pleasure associated with learning (Litman, 2005; Reio & 
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Callahan, 2004). Great learners preserve this childhood drive or regain it 
through another application of self-talk. Changing the inner narrative (see Figure 
16) can help spark our curiosity to learn (Andersen, 2016).  
 
 
 
 
 
 
 
 
 
 Learning to reason about our behaviors, focusing on positive sides 
associated with learning, and bringing more curiosity are some proven ways to 
get us to learn. Learning also requires efforts from the organizations we live in.  
Make It Safe to Learn 
 Argyris and Schön (1996) believe that defensive reasoning is widespread 
and focusing on an individual’s attitudes or commitment is never enough to 
make a real change. Perhaps the discovery of mirror neurons in the 1990s can 
provide the most scientific reason for this point of view. Through a series of 
studies, researchers found that the mirror neuron system that links perception 
and motor areas in the creation of presentations of international states creates 
presentations of other’s minds (Gallese, Fadiga, Fogassi, & Rizzolatti, 1996; 
Figure 16. Changing Your Inner Narrative                
(Andersen, 2016) 
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Carr, Iacoboni, Dubeau, Mazziotta, & Lenzi, 2003). It demonstrates that 
interpersonal attunement is wired in our brain, which also creates emotional 
resonance (Seigel, 2007, p. 164-169). Because of mirror neurons, both positive 
and negative emotional signals, especially from team leaders, can be picked up 
and followed quickly among individuals within organizations (Goleman & 
Boyatzis, 2008).  
 What if people live in organizations that can make them feel less 
defensive or, in other words, safer? Would it make their learning behaviors 
different? Creating an environment that provides people psychological safety 
has been widely advocated (Pascale & Sternin, 2005). Psychological safety 
refers to being able to show and employ one’s self without fear of negative 
consequences to self-images, status, or career (Kahn, 1990, p. 708). Studies 
show that four factors most directly influence psychological safety: interpersonal 
relationship, group and intergroup dynamics, management style and process, 
and organizational norms (Kahn, 1990). Thus, psychological safety can be seen 
as a group-level phenomenon.  
 Much of psychological safety-related research, particularly with the focus 
on organizational learning, comes from the work of Amy Edmondson, Professor 
of Leadership and Management at Harvard Business School. Organizational 
learning is defined as a process of detecting and correcting errors by Argyris 
and Schön (1996). Edmondson has pioneered the use of both quantitative and 
qualitative methods in understanding the relationship between learning 
behaviors in teams and psychological safety. Edmondson (1999) articulates 
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psychological safety as a shared belief that the team is safe for interpersonal 
risk taking. She also describes a team climate characterized by interpersonal 
trust and mutual respect in which people are comfortable being themselves.  
 In the late 1990s, Edmondson distinguished herself with a study of 51 
work teams (team type including functional, self-managed, and product/project 
development) in a manufacturing company. Seeking feedback, sharing 
information, asking for help, talking about errors, and experimenting are 
considered as examples of learning behaviors (Edmondson, 1999). Through 
extensive interviews, observation, and surveys in this study, she found that 
teams with higher psychological safety score 60% higher on innovation, 
engagement, and performance (Edmondson, 1999). The study results also 
prove her hypotheses that psychological safety can facilitate learning behavior 
in teams. It is mainly because psychological safety can alleviate one’s concern 
about others’ reactions to actions that have the potential for embarrassment or 
threat.  
 In the following years, the focus of her research shifted to the healthcare 
sector. In a study of work system failures on the front lines of care delivery in 
hospitals, Edmondson and Tucker (2003) analyzed data from 239 hours of 
observations of 26 nurses at nine hospitals. They uncovered that first-order 
problem solving can be counterproductive. “It keeps communication of problems 
isolated so that they do not surface as learning opportunities.” (Edmondson & 
Tucker, 2003, p. 60). They also attribute the lack of organizational learning from 
failures to an emphasis on individual vigilance, unit efficiency concerns. 
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Furthermore, they point out that people need to be able to talk about failures 
without fear of ridicule or punishment to learn from them. Additionally, they 
provide a comparison of the traditional and learning views of desirable employee 
behaviors (see Figure 17).  
 As psychological safety can cultivate an environment that supports 
learning, this may eventually lead to a learning organization (Edmondson, 1999).  
Co-Creating A Learning Organization  
 The notion of the learning organization flourished in the 1990s, 
stimulated most notably by Peter Senge. He asserts that in an increasingly 
dynamic, interdependent, and unpredictable world, organizations have to solicit 
efforts across levels rather than just follow the traditional top-down command 
approach. Integrating thinking and acting at all levels, organizations can leap 
Figure 17. Comparison of the Traditional and Learning Views of Desirable Employee Behaviors 
(Edmondson & Tucker, 2003, p. 69) 
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competition forward (Senge, 1990). To achieve that, he advocates that 
organizations become learning organizations. As Senge explained: 
The basic meaning of a “learning organization” – an organization that is 
continually expanding its capacity to create its future. For such an 
organization, it is not enough merely to survive. “Survival learning” or 
what is more often termed “adaptive learning” is important and indeed it 
is necessary. But for a learning organization, “adaptive learning” must be 
joined by “generative learning,” learning that enhances our capacity to 
create.  (Senge, 1990) 
 
Furthermore, he underscores the importance of distinguishing generative 
learning from adaptive learning as a part of intrinsic motivation.  
The impulse to learn in children goes deeper than desires to respond 
and adapt more effectively to environmental change. The impulse to 
learn, at its heart, is an impulse to be generative, to expand our ability. 
(Senge, 1990) 
 
 Building on the works of Peter Senge and other scholars, Amy 
Edmondson and her two colleagues, David Garvin, and Francesca Gino 
published the article “Is Yours a Learning Organization?” in Harvard Business 
Review. They present a comprehensive survey instrument for assessing learning 
within an organization through the lens of where individuals sit in the organization 
(Garvin et al., 2008). Through studies, they outline factors that are essential for 
organizational learning and adaptability in three building blocks: a supportive 
learning environment, concrete learning processes and practices, and leadership 
behavior. And each block has its vital subcomponents.  
 As the nourishing soil, a supportive learning environment has four 
distinguishing attributes: psychological safety, appreciation of differences, 
openness to new ideas, and time for reflection (Garvin et al., 2008). Without 
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feeling safe, people in the workplace can barely disagree with peers or authority 
figures, not to mention offering a minority viewpoint or appreciating alternative 
views from others. However, if people are comfortable expressing their thoughts 
as well as appreciating others, they are encouraged to take risks and explore 
unknowns. Their ability to think analytically can be further stretched in a 
supportive learning environment where time is allowed for reflection.  
 A learning organization is not cultivated effortlessly. It needs a series of 
concrete steps and systematically distributed within the organization. With this in 
mind, Garvin et al (2008) encourage organizations to build learning processes 
and practices around four areas: experimentation to develop and test new 
products and services; intelligence gathering to keep track of competitor, 
customer, and technological trends; analysis and interpretation information to 
identify and solve problems; and provide education and training to develop 
employees continuously. 
 Organizational learning is actively influenced by the behavior of leaders. 
Garvin et al (2008) consider leadership as the source of reinforcing learning 
behaviors. Peter Senge (1990) asserts that in a learning organization, leaders’ 
roles differ from that of the traditional decision-maker. They have to be designers, 
teachers, and stewards. As designers, they need to design share mental models 
and foster learning behaviors across levels. As teachers, they must give explicit 
attention to people, listen and inquiry.  
 In short, building a learning organization needs efforts across levels. The 
process is hard, such multidimensional learning can also reinvent organizations.  
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Summary 
 For the purpose of this capstone, this literature review has encompassed 
key research in agility, change, and learning from both theoretical and practical 
studies. By tracing agility from its origin in product development to its recent 
evolvement into pharma, it surfaces some veins of “agility”, the buzzword. 
Embracing agility in pharma is neither fully top-down nor bottom-up. The review 
follows with an exploration of several intentionally selected change 
management models and gravitates toward navigating the people side of 
change. Takeuchi and Nonaka (1986) underscore that the essence of agile is 
multilevel learning and multifunctional learning. Thus, this review is anchored in 
a study of learning with two dimensions: individual learning at work and 
organizational learning.  
 While “agility” and “agile” related topics have been widely discussed in 
recent years, surprisingly, it has less systematic studies compared with the 
other two discussed topics. However, it is commonly recognized that agility can 
incubate continuous improvement and innovation, which are considered as 
essential dynamic capabilities in pharma (Mahadevan et al., 2019). Albeit a 
limited agile related review with the focus on both pharma and learning and 
development, some essence of the Agile Manifesto can be further 
conceptualized to give life to learning and development.  
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CHAPTER 4 
CONCLUSIONS AND FURTHER EXPLORATION 
 
   At the beginning of this capstone, I had more questions than answers 
with respect to whether agile approaches could be applied to learning and 
development initiatives. My colleagues at BNC were strong advocates for agile, 
saying things such as, “use agile as a selling point”, “just run a pilot program 
and see”, “think about using ‘the trendy agile’ in your project”. This unsolved 
question ignited my idea of turning this experience into a capstone study. After 
the study, I find that agility and learning have become more interconnected than 
I thought (see Figure 18). 
    
 Studies of agility and organizational learning are deeply rooted in 
numerous quality improvement cases in the manufacturing industry. Takeuchi 
and Nonaka (1986) amplify the importance of multilevel learning and 
Figure 18. Comparison of the Personal Perception of Learning, Agility, and Change 
Before (left) and After (right) the Capstone Study (Tang, 2020) 
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multifunctional learning when organizations pursue agility. Peter Senge (1990) 
further underscores the essence of organizational learning to increase 
adaptiveness as well as to generate creativity.  
  
Conclusions  
   In my view, agility and learning closely interplay with each other in a 
helix (see Figure 19).  
 
Synergizing together, they can empower people in organizations to collaborate 
across levels and functions through three sets of values. These values can 
prepare organizations to tap into unknowns and uncertainty with dynamic 
capabilities (Teece, et al., 2016, p. 6).  
Start Small & Minimize Negatives   
   Starting small and breaking things into increments are fundamental 
features of agile approaches (Takeuchi & Nonaka, 1986; Agile Manifesto, n.d.).  
Figure 19. Value Created by the Helix of Learning (in blue) and Agility (in orange) 
(Tang, 2020) 
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It aims to make sure the value is delivered each time. Asking people to take 
small steps engages them in a deliberate process of discovery. It allows them to 
go beyond the obvious and shed light on their learning.  
   Beginning with small steps creates a relatively safe space for people to 
learn. This is critical for people who are not comfortable with change. For 
example, pharma R&D staff tend to have habitual ways of doing things that are 
rigid and sequential. If small steps work out, such as the pilot program in the 
BNC case, it can assure people and boost their confidence in taking bigger 
steps. Even if these steps fail, the feeling of “losing” is easier to be managed.  
   With less negative feelings, the mammalian brain is in a less active state. 
When the mammalian brain is freed up more, the prefrontal human brain takes 
over for higher intellectual functions, like learning (MacLean,1978).  
Shared Leadership & Multidimensional Learning 
   Compared with traditional management approaches, agile stands out by 
assembling diverse, cross-functional, and highly inclusive teams. The team 
leader, often referred to as the project owner, does not tell the team who should 
do what or how long tasks will take. The way that the team works relies heavily 
on collective intelligence (Takeuchi et al., 2016). In other words, each member of 
the team shares responsibility, and leadership is also shared. The shared 
leadership strives for having small commitments from individuals, which can 
move change forward agilely in the group (Onderick-Harvey, 2018).   
   Such shared leadership requires the team leader to be a process 
facilitator and to learn from team members actively. It not only changes the team 
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dynamics but also provides fertile soil for organizational learning. In the BNC 
case, Dian and Elizabeth created an inclusive environment for having both high-
level stakeholders and frontline scientists in the implementation process. The 
behavior of leaders is considered as the source of reinforcing learning behaviors 
(Senge, 1990; Garvin et al., 2008). In the agile environment, leaders need to 
foster learning behaviors across levels and functions, which is particularly 
important for science-driven organizations, like pharma (Fiore et al., 2019). 
Gradually, nurtured multidimensional learning behaviors can sustain a supportive 
learning environment.  
Stimulate Innovation & Ignite Curiosity 
   Experiential learning through small steps and multidimensional learning 
through collaboration creates an opening for many possibilities, including 
innovation. Takeuchi et al uncover (2016) that “innovation is what agile is all 
about.” Innovation is also placed at the heart of pharma as the engine for 
competitive advantage. To innovate something, we need to mobilize the 
intellectual capacity along with existing experiences to make a difference. It is a 
process of staying intellectually curious.  
   The nature of curiosity as an emotional-motivational state is in a positive 
correlation with the pleasure associated with learning (Litman, 2005; Reio & 
Callahan, 2004). When we get genuinely curious about something, our intrinsic 
motivation to learn is activated. Our impulse to learn is also an impulse to be 
generative and to expand our ability. More importantly, generative learning plays 
a pivotal role in creating a learning organization (Senge, 1990).  
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Implications of the Helix 
   To some degree, the helix of learning and agility is naturally structured 
with both stability and flexibility. By uncovering these three sets of values, I hope 
to offer a new perspective for learning and organizational development 
practitioners and leaders to see the interconnected relationship between learning 
and agility. Though this capstone focuses on pharma, I believe my findings can 
also provide some value for other organizations, especially regulated industries 
where both stable backbone functions and dynamic capabilities are desired.    
   The ability to learn continuously and move agilely is crucial for 
individuals and organizations in a world of rapid change. Done well, the helix 
can unlock potential in building learning capabilities from both individual and 
organizational levels. As Bill Gates said, “success today requires the agility and 
drive to constantly rethink, reinvigorate, react, and reinvent.” 
 
Further Exploration 
   Through the case and literature review, my initial goals of minimizing the 
current research gap and discovering the value of agility in learning seem 
reached. While I feel many questions that I held at the beginning are answered, 
there are still many questions to be answered on this journey that I want to 
explore further. These questions primarily focus on three areas.  
Quantitative Value of Agility in Learning 
   In the BNC case, the training solution used two established systems 
along with some existing team resources. All add layers of difficulty in 
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calculating the detailed project cost. Therefore, it is assumed that the net 
benefits (i.e., benefits minus costs) that agility brings (Teece et al., 2016) in the 
BNC case are positive.  
   One of the benefits of agile is commonly considered as cost-saving 
compared with the traditional sequential approaches in the world of product 
development (Cohen, 2009, p. 11-13). Are there relevant quantitative studies of 
the return on investment of agile? Furthermore, can any of these studies be the 
reference for exploring the quantitative value of agility in learning?  
Psychological Safety in Integration  
   Extensive studies of psychological safety underscore that it can create a 
better environment for learning. The process of fostering psychological safety is 
difficult and often needs efforts across the organization. While studying Edgar 
Schein’s theory of anxiety and how it can inhibit learning, I became aware of an 
intriguing perspective he offered. He indicates that psychological safety can be 
dramatically missing when a company is downsizing or undergoing a major 
structural change. It is extremely difficult to create psychological safety when 
organizations are pushing for greater workforce productivity at the same time 
(Schein, 2002). 
    It makes me realize the unique contextual background of BNC. 
Throughout my 12-week experience, I felt unspoken anxiety and observed 
different attitudes toward integration. In this case, the most important integration 
guiding principle was to make sure the top priority was business continuity. 
When I think about it, it seems like a rationally reasonable but emotionally 
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demanding request for people who live in uncertainty every day. I am curious 
and want to learn more about psychological safety in integration. I wonder how 
major structural changes might effect people’s learning behaviors.  
Agility and Organizational Culture 
   Edgar Schein (1984) constructs a formal definition of organizational 
culture that derives from a dynamic model of learning and group dynamics. He 
further defines cultural elements as learned solutions to problems. In the BNC 
case, I walked into a working environment where “the agile way of doing things” 
had been increasingly advocated organization-wide and supported by team 
leaders. The cultural element of agility was growing across organizational levels.  
   Would my experience be different if the organizational culture did not 
have the seed of agile? Would the project be accelerated if it happened in the 
world of software development where agile has deep roots? I want to know 
more about the relationship between agile and organizational culture. What kind 
of impact can agile bring to organizational culture? These are questions I will 
continue to explore.  
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CHAPTER 5 
PERSONAL REFLECTION 
 
   “Learning without reflection is a waste. Reflection without learning is 
dangerous.” 
- Confucius 
 
   Working at BNC in the summer of 2019, I felt that I was on an  
accelerated track with numerous details, multiple stakeholders, and many 
deliverable dates. It gave me a closer look at solution implementation in a highly 
regulated industry in a dynamic environment. Although I was in a position of little 
authority, the knowledge I learned in the MSOD program at Penn equipped me 
with insights and new ways of thinking to navigate the process. Lessons from 
the classroom were tested and proved transferable to different organizational 
contexts.  
   I ask myself if it would be different if I worked on this project without any 
knowledge of organizational dynamics. It is difficult to say how many things 
could be different. One thing is for sure: I would not be aware of the rich layers 
of a seemingly simple implementation process. This experience has greatly 
increased my confidence to become an organizational development consultant 
and a professional in the healthcare industry.  
   Writing this capstone was a lengthy journey of learning, stops, and 
surprises. It felt like running a marathon, a process with dynamic rhythm and 
resilience. As I near the end of the journey, I am grateful for the opportunity to 
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write this capstone. It holds a space for me to reflect on what I experienced, to 
learn areas I want to explore, and to start thinking about new paths to travel.   
   I believe the most valuable gift that I learned from my journey at Penn is 
understanding the power of stopping, reflecting, and exploring. Dr. Russo once 
said, “the consultant, as well as the leader, is a teacher.” I also feel a great 
responsibility as a helping professional, to inspire others and to continuously 
reinvent myself.  
   There are more miles to go.  
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